212 related articles for article (PubMed ID: 12668128)
21. Maximal lentivirus-mediated gene transfer and sustained transgene expression in human hematopoietic primitive cells and their progeny.
Amsellem S; Ravet E; Fichelson S; Pflumio F; Dubart-Kupperschmitt A
Mol Ther; 2002 Nov; 6(5):673-7. PubMed ID: 12436963
[TBL] [Abstract][Full Text] [Related]
22. Transduced CD34+ cells from adrenoleukodystrophy patients with HIV-derived vector mediate long-term engraftment of NOD/SCID mice.
Benhamida S; Pflumio F; Dubart-Kupperschmitt A; Zhao-Emonet JC; Cavazzana-Calvo M; Rocchiccioli F; Fichelson S; Aubourg P; Charneau P; Cartier N
Mol Ther; 2003 Mar; 7(3):317-24. PubMed ID: 12668127
[TBL] [Abstract][Full Text] [Related]
23. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
[TBL] [Abstract][Full Text] [Related]
24. Stem cell factor is essential for preserving NOD/SCID reconstitution capacity of ex vivo expanded cord blood CD34(+) cells.
Du Z; Wang Z; Zhang W; Cai H; Tan WS
Cell Prolif; 2015 Jun; 48(3):293-300. PubMed ID: 25899394
[TBL] [Abstract][Full Text] [Related]
25. Hybrid HIV/MSCV LTR enhances transgene expression of lentiviral vectors in human CD34(+) hematopoietic cells.
Choi JK; Hoang N; Vilardi AM; Conrad P; Emerson SG; Gewirtz AM
Stem Cells; 2001; 19(3):236-46. PubMed ID: 11359949
[TBL] [Abstract][Full Text] [Related]
26. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
[TBL] [Abstract][Full Text] [Related]
27. Lentiviral gene transfer into peripheral blood-derived CD34+ NOD/SCID-repopulating cells.
Scherr M; Battmer K; Blömer U; Schiedlmeier B; Ganser A; Grez M; Eder M
Blood; 2002 Jan; 99(2):709-12. PubMed ID: 11781260
[TBL] [Abstract][Full Text] [Related]
28. Lentiviral vectors with two independent internal promoters transfer high-level expression of multiple transgenes to human hematopoietic stem-progenitor cells.
Yu X; Zhan X; D'Costa J; Tanavde VM; Ye Z; Peng T; Malehorn MT; Yang X; Civin CI; Cheng L
Mol Ther; 2003 Jun; 7(6):827-38. PubMed ID: 12788657
[TBL] [Abstract][Full Text] [Related]
29. Efficient human immunodeficiency virus-based vector transduction of unstimulated human mobilized peripheral blood CD34+ cells in the SCID-hu Thy/Liv model of human T cell lymphopoiesis.
Douglas JL; Lin WY; Panis ML; Veres G
Hum Gene Ther; 2001 Mar; 12(4):401-13. PubMed ID: 11242532
[TBL] [Abstract][Full Text] [Related]
30. Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors.
Haas DL; Case SS; Crooks GM; Kohn DB
Mol Ther; 2000 Jul; 2(1):71-80. PubMed ID: 10899830
[TBL] [Abstract][Full Text] [Related]
31. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors.
Miyoshi H; Smith KA; Mosier DE; Verma IM; Torbett BE
Science; 1999 Jan; 283(5402):682-6. PubMed ID: 9924027
[TBL] [Abstract][Full Text] [Related]
32. Stable transduction with lentiviral vectors and amplification of immature hematopoietic progenitors from cord blood of preterm human fetuses.
Luther-Wyrsch A; Costello E; Thali M; Buetti E; Nissen C; Surbek D; Holzgreve W; Gratwohl A; Tichelli A; Wodnar-Filipowicz A
Hum Gene Ther; 2001 Mar; 12(4):377-89. PubMed ID: 11242530
[TBL] [Abstract][Full Text] [Related]
33. Hematopoietic stem cell targeting with surface-engineered lentiviral vectors.
Verhoeyen E; Cosset FL
Cold Spring Harb Protoc; 2009 Aug; 2009(8):pdb.prot5276. PubMed ID: 20147252
[No Abstract] [Full Text] [Related]
34. Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced engrafting human hematopoietic stem/progenitor cells.
Cui Y; Golob J; Kelleher E; Ye Z; Pardoll D; Cheng L
Blood; 2002 Jan; 99(2):399-408. PubMed ID: 11781219
[TBL] [Abstract][Full Text] [Related]
35. Comparison of three retroviral vector systems for transduction of nonobese diabetic/severe combined immunodeficiency mice repopulating human CD34+ cord blood cells.
Leurs C; Jansen M; Pollok KE; Heinkelein M; Schmidt M; Wissler M; Lindemann D; Von Kalle C; Rethwilm A; Williams DA; Hanenberg H
Hum Gene Ther; 2003 Apr; 14(6):509-19. PubMed ID: 12718762
[TBL] [Abstract][Full Text] [Related]
36. Human cord blood CD34+CD38- cell transduction via lentivirus-based gene transfer vectors.
Evans JT; Kelly PF; O'Neill E; Garcia JV
Hum Gene Ther; 1999 Jun; 10(9):1479-89. PubMed ID: 10395373
[TBL] [Abstract][Full Text] [Related]
37. In vivo gene delivery into hCD34+ cells in a humanized mouse model.
Frecha C; Fusil F; Cosset FL; Verhoeyen E
Methods Mol Biol; 2011; 737():367-90. PubMed ID: 21590405
[TBL] [Abstract][Full Text] [Related]
38. Lentiviral transduction of P140K MGMT into human CD34(+) hematopoietic progenitors at low multiplicity of infection confers significant resistance to BG/BCNU and allows selection in vitro.
Zielske SP; Gerson SL
Mol Ther; 2002 Apr; 5(4):381-7. PubMed ID: 11945064
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of a cytokine combination including thrombopoietin for improved transduction of a retroviral gene into G-CSF-mobilized CD34+ human blood cells.
Kim HJ; Okamoto Y; Ito M; Takaue Y; Kawano Y; Watanabe T; Yamaue T; Tohda Y; Ogose T; Shimada T; Shimosaka A; Kuroda Y
Stem Cells; 1997; 15(5):347-52. PubMed ID: 9323796
[TBL] [Abstract][Full Text] [Related]
40. Efficiency of transgenic T cell generation from gene-marked cultured human CD34+ cord blood cells is determined by their maturity and the cytokines present in the culture medium.
Verhasselt B; Naessens E; De Smedt M; Plum J
Gene Ther; 2000 May; 7(10):830-6. PubMed ID: 10845720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
